you're reading...
Innovation

Cleveland Clinic researchers identify urgent need for Alzheimer’s drug development

Analysis of clinical trials shows pipeline for therapeutics is small; 99.6 percent of drug attempts fail
Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer’s disease (AD), revealing an urgent need to increase the number of agents entering the AD drug development pipeline and progressing successfully towards new therapy treatments. The paper, “Alzheimer’s Disease Drug Development Pipeline: Few

Learn more …

Advertisements

About innovationtoronto

An early look at the things coming at us that could help or hurt from global universities and research institutions

Discussion

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: